BRIEF-Amicus Therapeutics to buy Scioderm Inc for $229 mln

* To acquire rare disease company Scioderm Inc for $229 million in cash and stock
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.